A national lab network can identify emerging threats and track resistance trends.
Though results are mixed, point-of-care testing could reduce antibiotic use.
Meta-analysis shows a 21% higher antibiotic prescribing rate in patients who tested negative for malaria.
The test could reduce the likelihood of antibiotic-pathogen mismatch by almost 67%.
The National Institutes of Health (NIH) today said it has selected 10 semifinalists in the first phase of a federal prize competition that will award up to $20 million for innovative tests that can rapidly diagnose bacterial infections and identify antibiotic resistant bacteria.
The US Food and Drug Administration (FDA) yesterday cleared the expanded use of a diagnostic test for lower respiratory tract infections and sepsis and allowed marketing for a test that can identify organisms that cause bloodstream infections, according to two agency news releases.
The US Centers for Disease Control and Prevention (CDC) today awarded more than $14 million toward novel approaches to combat antibiotic resistance, including those that address a person's microbiome, or the vast population of microorganisms that live inside and on the body.
Two studies show the potential of genetics to quickly tell bacterial from viral infections in feverish infants.
The test checks patient specimens for the presence of 5 different genetic markers.
Steps include added lab capacity, a sequencing database, and boosts for drug development.
